Argus downgraded Centene (NYSE:CNC) to Hold from Buy on Thursday, citing the Medicaid-focused insurer’s recent Q4 2024 results and projecting an uncertain outlook for the company’s operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback